Clinical Trial Update: Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing safety and efficacy of basal insulin Lantus (insulin glargine) versus NPH insulin, added to oral antidiabetic drugs, in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED